DE60034580D1 - Peptid zur behandlung von nervenerkrankungen - Google Patents

Peptid zur behandlung von nervenerkrankungen

Info

Publication number
DE60034580D1
DE60034580D1 DE60034580T DE60034580T DE60034580D1 DE 60034580 D1 DE60034580 D1 DE 60034580D1 DE 60034580 T DE60034580 T DE 60034580T DE 60034580 T DE60034580 T DE 60034580T DE 60034580 D1 DE60034580 D1 DE 60034580D1
Authority
DE
Germany
Prior art keywords
peptide
treatment
nerve diseases
agent
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60034580T
Other languages
English (en)
Other versions
DE60034580T2 (de
Inventor
Takashige Nishikawa
Kenji Hirate
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Chemiphar Co Ltd
Original Assignee
Nippon Chemiphar Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co Ltd filed Critical Nippon Chemiphar Co Ltd
Application granted granted Critical
Publication of DE60034580D1 publication Critical patent/DE60034580D1/de
Publication of DE60034580T2 publication Critical patent/DE60034580T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE60034580T 1999-09-09 2000-09-08 Peptid zur behandlung von nervenerkrankungen Expired - Fee Related DE60034580T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP25515999 1999-09-09
JP25515999A JP2001072602A (ja) 1999-09-09 1999-09-09 神経疾患治療剤
PCT/JP2000/006150 WO2001017545A1 (fr) 1999-09-09 2000-09-08 Medicaments destines aux maladies nerveuses

Publications (2)

Publication Number Publication Date
DE60034580D1 true DE60034580D1 (de) 2007-06-06
DE60034580T2 DE60034580T2 (de) 2007-12-27

Family

ID=17274893

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60034580T Expired - Fee Related DE60034580T2 (de) 1999-09-09 2000-09-08 Peptid zur behandlung von nervenerkrankungen

Country Status (8)

Country Link
EP (1) EP1210948B8 (de)
JP (1) JP2001072602A (de)
KR (1) KR100699737B1 (de)
CN (1) CN1170585C (de)
AT (1) ATE360432T1 (de)
AU (1) AU6876200A (de)
DE (1) DE60034580T2 (de)
WO (1) WO2001017545A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4188115B2 (ja) 2003-03-14 2008-11-26 ブラザー工業株式会社 画像形成装置

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69013742T2 (de) * 1989-04-15 1995-03-23 Nippon Chemiphar Co Peptide und diese Peptide enthaltende Wirkstoffe gegen Dementia.
JPH11171786A (ja) * 1997-12-12 1999-06-29 Nippon Chemiphar Co Ltd ペプチドを有効成分として含有する向精神薬

Also Published As

Publication number Publication date
EP1210948A1 (de) 2002-06-05
AU6876200A (en) 2001-04-10
KR20020041811A (ko) 2002-06-03
DE60034580T2 (de) 2007-12-27
EP1210948A4 (de) 2004-07-28
EP1210948B8 (de) 2007-07-04
EP1210948B1 (de) 2007-04-25
JP2001072602A (ja) 2001-03-21
CN1170585C (zh) 2004-10-13
KR100699737B1 (ko) 2007-03-27
CN1384752A (zh) 2002-12-11
WO2001017545A1 (fr) 2001-03-15
ATE360432T1 (de) 2007-05-15

Similar Documents

Publication Publication Date Title
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
ATE389400T1 (de) Cis-2,4,5- triphenyl-imidazoline und ihre verwendung bei der behandlung von tumoren
EA200200208A1 (ru) Синергитическая композиция
FI950309A0 (fi) Proliiniamidijohdannaisia
DE60026155D1 (de) Einige alkylendiamin-substituierte heterocyclen
MXPA04001037A (es) Derivados de n-fenilpirrol guanidina como ligandos del receptor de melanocortina.
EA200400022A1 (ru) Соединения и способы лечения или предупреждения инфекций flavivirus
DE69736441D1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
MXPA04012965A (es) Inhibidores virales.
NO20034204L (no) Farmasöytiske kombinasjoner til behandling av kreft
ATE337316T1 (de) Imidazo 1,2-aöpyridin-derivate zur prophylaxe und behandlung von herpes-infektionen
HK1069339A1 (en) Substituted diketopiperazines as oxytocin antagonists
ATE399782T1 (de) Zur behandlung von schmerzen geeignete phenylcarbonsäureamidverbindungen
ATE357438T1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
DE69834500D1 (de) Xanthinderivative zur behandlung von hirnischämie
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
EA200100140A1 (ru) Терапевтическая композиция на основе флавоноидов для применения в лечении опухолей цитотоксическими агентами
BR9909870A (pt) Pirrolidinas como inibidores de neuraminidases
EA200100141A1 (ru) Терапевтическая композиция на основе изофлавоноидов для применения в лечении опухолей цитотоксическими агентами
EA200201232A1 (ru) Производные сульфонамида
DE60034580D1 (de) Peptid zur behandlung von nervenerkrankungen
ATE267194T1 (de) Medikamente geeignet zur behandlung von proliferativen erkrankungen
EA200201234A1 (ru) Производные сульфонамида
HK1080768A1 (en) Use of epothilone derivatives for the treatment ofhyperparathyroidism

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee